Gastrointestinal symptoms are frequently reported in the general population and are associated with an altered quality of life. It is estimated that up to 20% of adults in certain areas complain of gastrointestinal symptoms corresponding to Irritable Bowel Syndrome (IBS) (abdominal pain, bloating, constipation, diarrhea …). This condition affects hundreds of millions of people worldwide.
The leaflet describes the latest clinical study conducted on 456 IBS volunteers, presented in october during the United European Gastroenterology virtual week. In this study, ibSium® confirmed its efficacy to alleviate abdominal pain and demonstrated its statiscally significant beneficial effects on the global quality of life score improvement. The daily ibSium®’s supplementation was also associated with lower food avoidance, better body image, less interference with daily activities and lower dysphoria [a better state of mind, better mood, less anxiety or depression].
With ibSium®, benefit from a powerful and unique probiotic yeast to improve your daily digestive comfort!
